Hemolytic uremic syndrome: Epidemiological and clinical features of a pediatric population in tuscany

Kidney and Blood Pressure Research

Volumn 33, Issue 5, 2010, Pages 399-404

  Micheletti, Maria Vittoria ^a   Lavoratti, Giancarlo ^a   Materassi, Marco ^a   Pela, Ivana ^a  

^a UNIVERSITY OF FLORENCE   (Italy)

Author keywords

Acute renal failure; Diarrhea; Hemolytic uremic syndrome; Shiga toxin producing Escherichia coli

Indexed keywords

COMPLEMENT FACTOR H;

AGE DISTRIBUTION; ANURIA; ARTICLE; CHILD; CHRONIC KIDNEY DISEASE; CLINICAL FEATURE; HEMOLYTIC UREMIC SYNDROME; HUMAN; HYPERTENSION; INCIDENCE; ITALY; OLIGOANURIA; PERTUSSIS; PRIORITY JOURNAL; PROGNOSIS; SHIGA TOXIN PRODUCING ESCHERICHIA COLI; UPPER RESPIRATORY TRACT INFECTION; URINARY TRACT INFECTION;

ADOLESCENT; AGE DISTRIBUTION; CHILD; CHILD, PRESCHOOL; CHRONIC DISEASE; HEMOLYTIC-UREMIC SYNDROME; HUMANS; INCIDENCE; INFANT; INFANT, NEWBORN; ITALY; KIDNEY DISEASES; PROGNOSIS; RETROSPECTIVE STUDIES; SHIGA-TOXIGENIC ESCHERICHIA COLI;

EID: 77957757109     PISSN: 14204096     EISSN: None     Source Type: Journal    
DOI: 10.1159/000320385     Document Type: Article

References (33)

1. Loirat C, Taylor CM: Hemolytic uremic syndrome; in Avner ED, Harmon WE, Niaudet P (eds): Pediatric Nephrology, ed 5. Philadelphia, Lippincott, Williams & Wilkins 2008, pp 887-915.
2. Moake JL: Thrombotic microangiopathies. N Engl J Med 2002; 347: 589-600.
3. Ruggenenti P, Noris M, Remuzzi G: Throm-botic microagiopathy, hemolytic uremic syndrome, and thrombotic thrombocytopenic purpura. Kidney Int 2001; 60:831-846. (Pubitemid 34205784)
4. Noris M, Remuzzi G: Haemolytic uremic syndrome. J Am Soc Nephrol 2005; 16:1035-1050.
5. Thorpe CM: Shiga toxinproducing Escherichia coli infection. Clin Infect Dis 2004; 38: 1298-1303.
6. Scheiring J, Andreoli SP, Zimmerhackl LB: Treatment and outcome of Shiga-toxin-asso-ciated hemolytic uremic syndrome (HUS). Pediatr Nephrol 2008; 23: 1749-1760.
7. Copelovitch L, Kaplan BS: Streptococcus pneumoniae-associated hemolytic uremic syndrome. Pediatr Nephrol 2008; 23: 951-956.
8. Pela I, Seracini D, Caprioli A, Castelletti F, Giammanco A: Hemolytic uremic syndrome in an infant following Bordetella pertussis infection. Eur J Clin Microbiol Infect Dis 2006; 25:515-517.
9. Loirat C, Noris M, Fremeaux-Bacchi V: Complement and the atypical hemolytic ure-mic syndrome in children. Pediatr Nephrol 2008; 23: 1957-1972.
10. Noris M Remuzzi G: Atypical hemolyticuremic syndrome. N Engl J Med 2009; 361: 1676-1687.
11. Frémeaux-Bacchi V, Miller EC, Liszewski MK, Strain L, Blouin J, Brown AL, et al: Mutations in complement C3 predispose to development of atypical haemolytic uraemic syndrome. Blood 2008; 112:4948-4952.
12. Noris M, Brioschi S, Caprioli J, Todeschini M, Bresin E, Porrati F, Gamba S, Remuzzi G; International Registry of Recurrent and Familial HUS/TTP: Familial haemolyticuremic syndrome and MCP mutation. Lancet 2003; 362:1542-1547.
13. Kavanagh D, Kemp EJ, Mayland E, Winney RJ, Duffield JS, Warwick G, et al: Mutations in complement factor I predispose to the development of atypical HUS. J Am Soc Nephrol 2005; 16:2150-2155.
14. Sharma AP, Greenberg CR, Prasad AN, Prasad C: Hemolytic uremic syndrome (HUS) secondary to cobalamin C (cblC) disorder. Pediatr Nephrol 2007; 22:2097-2103.
15. Lynn RM, O'Brien SJ, Taylor CM, Adak GK, Chart H, Cheasty T, et al: Childhood hemolytic uremic syndrome, United Kingdom and Ireland. Emerg Infect Dis 2005; 11: 590-596.
16. Gerber A, Karch H, Allerberger F, Verweyen HM, Zimmerhackl LB: Clinical course and the role of Shiga toxinproducing Escherich-ia coli infection in the haemolytic-uremic syndrome in pediatric patients, 1997-2000, in Germany and Austria: a prospective study. J Infect Dis 2002; 18 6: 493-500.
17. Espié E, Grimont F, Mariani-Kurkdjian P, Bouvet P, Haeghebaert S, Filliol I, et al: Surveillance of hemolytic uremic syndrome in chi ld ren less than 15 yea rs of age, a system to monitor O157 and non-O157 Shiga toxinproducing Escherichia coli infections in France, 1996-2006. Pediatr Infect Dis 2008;J27: 595-601.
18. Lopez EL, Diaz M, Grinstein S, Devoto S, Mendilaharzu F, Murray BE, et al: Hemolyticuremic syndrome and diarrhea in Argentine children: the role of Shigalike toxins. J Infect Dis 1989; 160:469-475.
19. Schiffelri A, von Vigier RO, Fontana M, Spartà G, Schmid H, Bianchetti MG, Rudin C; Swiss Pediatric Surveillance Unit: hemolytic uremic syndrome in Switzerland: a nationwide surveillance 1997-2003. Eur J Pediatr 2010; 169: 591-598.
20. Elliott EJ, Robins-Browne RM, O'Loughlin EV, Bennett-Wood V, Bourke J, Henning P, Hogg GG, Knight J, Powell H, Redmond D, Contributors to the Australian Paediatric Surveillance Unit: Nationwide study of hae-molytic uremic syndrome: clinical, microbiological, and epidemiological features. Arch Dis Child 2001; 85:125-131.
21. Banatvala N, Griffin PM, Greene KD, Barrett TJ, Bibb WF, Green JH, Wells JG; Hemolytic Uremic Syndrome Study Collaborators: The United States National Prospective He-molytic uremic syndrome study: microbio-logic, serologic, clinical, and epidemiologic f indings. J Infect Dis 2001; 183: 1063-1070.
22. Kinney JS, Gross TP, Porter CC, Rogers MF, Schonberger LB, Hurwitz ES: hemolyticuremic syndrome: a population-based study in Washington, DC and Baltimore, Maryland. Am J Public Health 1988; 78:64-65.
23. Cummings KC, Mohle-Boetani JC, Werner SB, Vugia DJ: Population-based trends in pe-diatric hemolytic uremic syndrome in California, 1994-1999: substantial underreporting and public health implications. Am J Epidemiol 2002; 155:941-948.
24. Caprioli J, Castelletti F, Bucchioni S, Betti-naglio P, Bresin E, Pianetti G, Gamba S, Bri-oschi S, Daina E, Remuzzi G, Noris M; International Registry of Recurrent and Familial HUS/TTP: Complement factor H mutations and gene polymorphisms in haemo-lytic uraemic syndrome: the C-257T, the A2089G and the G2881T polymorphisms are strongly associated with the disease. Hum Mol Genet 2003; 12:3385-3395.
25. Andreoli SP, Bergstein JM: Acute rhabdomy-olysis associated with hemolyticuremic syndrome. J Pediatr 1983; 103:78-80.
26. Pena DR, Vaccarello M, Neiberger RE: Severe hemolytic uremic syndrome associated with rhabdomyolysis and insulin-dependent diabetes mellitus. Child Nephrol Urol 1991; 11: 223-227. http://www.simi.iss.it/Enternet/dati-seu. asp.
27. Blanco M, Padola NL, Krüger A, Sanz ME, Blanco JE, González EA, et al: Virulence genes and intimin types of Shiga-toxin-pro-ducing Escherichia coli isolated from cattle and beef products in Argentina. Int Microbiol 2002; 7: 269-276.
28. Ake JA, Jelacic S, Ciol MA, Watkins SL, Murray KF, Christie DL, Klein EJ, Tarr PI: Relative nephroprotection during Escherichia coli O157:H7 infections: association with intravenous volume expansion. Pediatrics 2005; 115:e673-e 680.
29. Tozzi AE, Caprioli A, Minelli F, Gianviti A, De Petris L, Edefonti A, Montini G, Ferretti A, De Palo T, Gaido M, Rizzoni G; Hemolytic Uremic Syndrome Study Group: Shiga-toxin producing Escherichia coli infections associated with hemolytic uremic syndrome, Italy, 1988-2000. Emerg Infect Dis 2003; 9: 106-108.
30. Pomajzl RJ, Varman M, Holst A, Chen A: Hemolytic uremic syndrome (HUS)-incidence and etiologies at a regional Children's Hospital in 2001-2006. Eur J Clin Microbiol Infect Dis 2009; 8: 1431-1435.
31. Oakes RS, Kirkham JK, Nelson RD, Siegler RL: Duration of oliguria and anuria as predictors of chronic renal-related sequelae in post-diarrheal hemolytic uremic syndrome. Pediatr Nephrol 2008; 23: 1303-1308.
32. Garg AX, Suri RS, Barrowman N, Rehman F, Matsell D, Rosas-Arellano MP, Salvadori M, Haynes RB, Clark WF: Long-term renal prognosis of diarrhea-associated hemolytic uremic syndrome: a systematic review, meta-analysis, and meta-regression. JAMA 2003; 290:1360-1370.
33. Ariceta G, Besbas N, Johnson S, Karpman D, Landau D, Licht C, Loirat C, Pecoraro C, Taylor CM, Van de Kar N, Vandewalle J, Zimmerhackl LB; European Paediatric Study Group for HUS: Guideline for the investigation and initial therapy of diarrhea-negative hemolytic uremic syndrome. Pediatr Nephrol 2009; 24:687-696.